Arspharm, s.r.o.

Active
IČO 36646865limited liability company (s.r.o.)Founded 2006Žiar nad Hronom

Key figures

1 732 205 €-11,7%
Revenue 2025
+11,1%
Average annual growth 2020–2025
0500 k1 m1,5 m2 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 2 805 €.

Low confidence: the amount exceeds the retained earnings from which dividends can be distributed — probably a merger, an opening balance adjustment or an error in the financial statements.

History
2025 ~2 805 €
20240 €
20230 €
20220 €
20210 €

Summary: Arspharm, s.r.o.

What kind of company is it?

Arspharm, s.r.o. (IČO 36646865) is a limited liability company (s.r.o.). The company was incorporated in 2006 and has existed for 20 years. Registered office according to the register: Žiar nad Hronom. Main activity according to the Statistical Office: maloobchod s farmaceutickými výrobkami (SK NACE 4773). Size category by number of employees: 2 employees.

Who runs the company and who owns it?

The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 13 280 €.

How is the company doing financially?

Revenue for 2025 was 1 732 205 €, down 11,7 % on the previous year (1 962 622 €). From 2020 to 2025, revenue grew by an average of 11,1 % per year. 2025 ended with a loss of 2 961 €. The company was profitable in 2 of the 6 reported years. Personnel costs for 2025 were 50 060 €.

What should you look out for?

Equity was negative at the end of 2025 (-127 853 €).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 19. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)1 037 2851 060 9331 385 7841 962 6221 732 205
Profit for the reporting year-14 5601 655-12 2089 507-2 961
Retained earnings of previous periods-119 762-134 322-133 994-146 202-139 500
Total assets213 990196 179169 311251 840251 436
Total liabilities335 032315 566300 905373 927379 289
Total equity-121 042-119 387-131 594-122 087-127 853
Calculated dividends00002 805

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a company to see its connections.

100 %directorsole shareholder100 % · directorArspharm, s.r.o.Arspharm, s.r.o.IŠIgor ŠajgalíkIgor ŠajgalíkIKJUDr. Igor KovalJUDr. Igor Koval
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements14

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 4773)
Arspharm, s.r.o. (IČO 36646865) – revenue 1,7M €, loss 3K €